NEWS
Tags: 

Increased licensing of bioinformatics software

Genmab in the Netherlands has doubled the number of licenses it owns for ActivityBase XE, which it uses to capture and store plate-based screening data.

The biotech company needed a flexible solution to handle the data produced from the functional screening of human monoclonal antibody therapies, used in the treatment of cancer and infectious diseases.

ActivityBase XE enables the scientists to capture, validate and visualise the data from antibody screening in a contextually rich environment.

Arnout Gerritsen, senior manager of lead identification at Genmab, commented: ‘The introduction of ActivityBase XE into our Hybridoma Discovery department has significantly improved the efficiency of our human antibody screening campaigns. The flexibility inherent within the ActivityBase XE module enables us to use both Excel and non-Excel templates in our analysis.’

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori

Feature

Robert Roe looks at the latest simulation techniques used in the design of industrial and commercial vehicles

Feature

Robert Roe investigates the growth in cloud technology which is being driven by scientific, engineering and HPC workflows through application specific hardware

Feature

Robert Roe learns that the NASA advanced supercomputing division (NAS) is optimising energy efficiency and water usage to maximise the facility’s potential to deliver computing services to its user community

Feature

Robert Roe investigates the use of technologies in HPC that could help shape the design of future supercomputers